BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) and bioMerieux (OTCMKTS:BMXMF – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations.
Profitability
This table compares BrightSpring Health Services and bioMerieux’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
BrightSpring Health Services | 0.55% | 9.42% | 2.65% |
bioMerieux | N/A | N/A | N/A |
Volatility & Risk
BrightSpring Health Services has a beta of 2.25, suggesting that its share price is 125% more volatile than the S&P 500. Comparatively, bioMerieux has a beta of 0.74, suggesting that its share price is 26% less volatile than the S&P 500.
Valuation & Earnings
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
BrightSpring Health Services | $11.27 billion | 0.30 | -$18.06 million | $0.31 | 62.45 |
bioMerieux | $4.31 billion | 3.96 | $467.68 million | N/A | N/A |
bioMerieux has lower revenue, but higher earnings than BrightSpring Health Services.
Analyst Recommendations
This is a summary of recent recommendations for BrightSpring Health Services and bioMerieux, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
BrightSpring Health Services | 0 | 1 | 10 | 0 | 2.91 |
bioMerieux | 0 | 1 | 0 | 1 | 3.00 |
BrightSpring Health Services presently has a consensus target price of $24.90, indicating a potential upside of 28.62%. Given BrightSpring Health Services’ higher probable upside, equities research analysts clearly believe BrightSpring Health Services is more favorable than bioMerieux.
Summary
BrightSpring Health Services beats bioMerieux on 7 of the 11 factors compared between the two stocks.
About BrightSpring Health Services
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.
About bioMerieux
bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.